Registered as a medical technology company, Entellus Medical, Inc. engages in the development and commercialization of various products that are intended for treatment of patients with chronic sinusitis.
Headquartered in Plymouth, Minnesota, Entellus Medical, Inc. creates products that minimally invasive. Their flagship product is the XprESS family of products, these medical products are used by physicians to open narrowed or obstructed sinus drainage pathways. Partnered with balloon sinus dilation, these medical advancements are used to treat patients with symptomatic inflammation of the nasal sinuses. ENT (ear, nose and throat) physicians across the country and in some select international markets continue to make use of these products. The biggest markets of the business are in the United States and in Canada.
Incorporated in August 2006, Entellus Medical, Inc. continues to publicly trade on the NASDAQ Global Market. Common shares of the business are marketed using the ticker symbol ENTL.